Postbiotics alleviate cognitive impairment and neuroinflammation via gut-brain axis and TLR4/MyD88/NLRP3 pathway

Nov 21, 2025Food research international (Ottawa, Ont.)

Postbiotics may reduce memory problems and brain inflammation through the gut-brain connection and immune signaling pathway

AI simplified

Gut-Brain Axis on OpenScience ↗PubMed ↗DOI ↗

Abstract

Postbiotics derived from specific probiotic strains may improve cognitive deficits and reduce neuroinflammation in Alzheimer's disease models.

Three postbiotics from Bifidobacterium animalis, Lactiplantibacillus plantarum, and Lactobacillus paracasei were evaluated in a model of Alzheimer’s disease induced by D-galactose and aluminum chloride.
These postbiotics reduced cognitive deficits, anxiety-like behaviors, neuronal degeneration, and amyloid-β accumulation.
Suppression of microglial activation and neuroinflammation was observed, linked to the TLR4/MyD88/NLRP3 signaling pathway.
Gut microbiota remodeling occurred, characterized by an increase in Lachnospiraceae, Ruminococcus, and Lactobacillus, alongside a decrease in Muribaculaceae.
Postbiotic administration elevated fecal short-chain fatty acids and identified 11 metabolites, including indole derivatives and cholinergics, that may contribute to neuroprotective effects.

AI simplified

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cerebral amyloid-β deposition, neurofibrillary tangles of hyperphosphorylated tau, and chronic neuroinflammation. Growing evidence underscores the role of the gut-brain axis in mediating bidirectional communication between the gut and the central nervous system. Postbiotics, non-viable microorganisms and/or ingredients that are beneficial to the host's health, have emerged as promising modulators of brain function via this axis. Herein, we evaluated the neuroprotective effects of three postbiotics derived from Bifidobacterium animalis subsp. lactis IOBL07, Lactiplantibacillus plantarum IOB602 and Lactobacillus paracasei IOB413 in a D-galactose/AlCl-induced AD rats. These postbiotics ameliorated cognitive deficits and anxiety-like behaviors, reduced neuronal degeneration and Aβ accumulation, and suppressed microglial activation and neuroinflammation via the TLR4/MyD88/NLRP3 signaling pathway. 16S rDNA sequencing revealed that postbiotics intervention induced substantial gut microbiota remodeling, selectively enriching Lachnospiraceae, Ruminococcus and Lactobacillus, while depleting Muribaculaceae. Postbiotic administration also elevated fecal short-chain fatty acid levels. Metabolomics analysis identified 11 metabolites, including indole derivatives, cholinergics and niacinamides, that were uniquely enriched in the IOB602 group. These metabolites may underlie its anti-AD effects by attenuating oxidative stress, modulating neuroinflammation, and enhancing mitochondrial function. Together, these findings provide a foundation for developing postbiotic-based adjuvant therapies against AD pathogenesis. 3

Full Text

Full text is available at the source.

View full text (XML) ↗View full text ↗

Postbiotics alleviate cognitive impairment and neuroinflammation via gut-brain axis and TLR4/MyD88/NLRP3 pathway

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the gut-brain axis brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the gut-brain axis brief